Josiah Craver

Finansdirektör/CFO på FAETH THERAPEUTICS, INC.

Förmögenhet: - $ per 2026-05-31

43 år

Health Technology

Consumer Services

Profil

Josiah Craver currently works at Sensei Biotherapeutics, Inc., as SVP-Finance, Chief Financial & Accounting Officer from 2024.
Mr. Craver also formerly worked at Kala Bio, Inc., as Senior Vice President & Controller and Solid Biosciences, Inc., as Vice President-Finance in 2020.
Mr. Craver received his undergraduate degree and graduate degree from Stonehill College, Inc.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
FAETH THERAPEUTICS, INC. -.--%	2026-03-31	0 ( -.--% )	- $	2026-05-31

Aktiva positioner av Josiah Craver

Företag	Position	Start
FAETH THERAPEUTICS, INC.	Finansdirektör/CFO	2024-09-17

Alla aktiva positioner av Josiah Craver

Tidigare kända positioner av Josiah Craver

Företag	Position	Slut
SOLID BIOSCIENCES INC.	Comptroller/Controller/Revisor	2020-03-01
KALA BIO, INC.	Comptroller/Controller/Revisor	-

Se detaljerna i Josiah Cravers erfarenhet

Josiah Cravers utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Josiah Cravers erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Kala Bio, Inc. Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies	Health Technology
Stonehill College, Inc. Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Solid Biosciences, Inc. Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease	Health Technology
Sensei Biotherapeutics, Inc. Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease	Health Technology